Selumetinib (Selumetinib) effects and efficacy

Selumetinib is a kind of kinase inhibitor. It works by blocking the activity of abnormal proteins that signal tumor growth, which helps stop or slow tumor growth. Selumetinibtrade nameKoselugo is a drug used to treat children two years and older with INeurofibromatosis Type I(NF1), a genetic disorder of the nervous system that causes tumors to grow on the nerves.

Selumetinib is a non-ATP competitive inhibitor of mitogen-activated protein kinase kinase kinases 1 and 2 (MEK1 and MEK2). By selectively targeting MEK1 and MEK2, selumetinib inhibits the oncogenic downstream effects of the Raf-MEK-ERK signaling pathway, which are often overactive in certain types of cancer. In fact, one study examining the effects of selumetinib in children with NF-1 found that treatment with the anti-tumor drug reduced tumor size. Reductions in tumor-related pain and improvements in overall function were also subjectively reported. Selumetinib has minimal off-target activity, which contributes to its impressive safety profile.

SelumetinibCommon side effects are headache, nausea, vomiting, abdominal pain, diarrhea, and fatigue, Musculoskeletal pain(Body pain affecting bones, muscles, ligaments, tendons, and nerves), fever, dry skin, acneiform rash(Acne)and other rashes, Stomatitis(Inflammation of the mouth and lips), paronychia(Infection of the skin around toenails or fingernails)and itching. There is an original research version of selumetinib overseas, with a retail price of 10mg 60 tablets50,000around. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.